Experimental Screening for “Systemic Adjuvants of Immunity” Applicable in Cancer Immunotherapy
- 1 January 1974
- book chapter
- Published by Springer Nature
- Vol. 33 (9), 149-165
- https://doi.org/10.1007/978-3-642-49284-6_21
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Active immunotherapy of mouse RC 19 and E ♀ K1 leukaemias applied after the intravenous transplantation of the tumour cellsCellular and Molecular Life Sciences, 1971
- Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomasCellular Immunology, 1970
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Absence of Synergism between Thymus and Bone Marrow in Graft-versus-Host ReactionsExperimental Biology and Medicine, 1969
- STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A METHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG)The Journal of Experimental Medicine, 1966
- A study of polyadenylic acid at neutral pHJournal of Molecular Biology, 1966
- PROLONGED SURVIVAL OF ALLOGENEICTransplantation, 1964
- Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the MouseNature, 1959
- POLYNUCLEOTIDES. I. MOLECULAR PROPERTIES AND CONFIGURATIONS OF POLYRIBOADENYLIC ACID IN SOLUTION1Journal of the American Chemical Society, 1957